Home LiteratureArticle Details
PMID: 10203523 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant.

Journal of clinical microbiology ·Vol. 37 ·No. 5 ·1999-05-00 ·Pages 1567-9

Doglio A, Laffont C, Caroli-Bosc FX, Rochet P, Lefebvre J

Abstract

The first and second generations of the Cobas Amplicor HCV assay were compared among patients at risk of hepatitis C virus (HCV) infection. The second-generation test was found to be of greater sensitivity and of good specificity among clinical specimens containing HCV RNA of different genotypes. Finally, this new test is shown to predict the outcome of interferon therapy better.

MeSH Terms
Hepacivirus/genetics Hepatitis C/therapy Humans Interferons/therapeutic use RNA, Viral/analysis Sensitivity and Specificity
Chemicals
RNA, Viral Interferons
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Doglio A
Laboratoire de Virologie, Faculté de Médecine, 06107 Nice, France. doglio@unice.fr
Laffont C
Caroli-Bosc F X
Rochet P
Lefebvre J
References (11)
11 references, click to expand
  1. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions.
    Gene. 1990 Sep 1;93(1):125-8 PMID: 2227421
  2. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay.
    J Clin Microbiol. 1993 Apr;31(4):882-6 PMID: 8385151
  3. Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA.
    J Hepatol. 1996 Jan;24(1):33-7 PMID: 8834022
  4. Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management.
    J Clin Microbiol. 1996 Nov;34(11):2778-83 PMID: 8897182
  5. COBAS AMPLICOR: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR.
    Clin Chem. 1996 Dec;42(12):1915-23 PMID: 8969626
  6. Rapid genotyping of hepatitis C virus by direct cycle sequencing of PCR-amplified cDNAs and capillary electrophoresis analysis.
    Res Virol. 1998 Jul-Aug;149(4):219-27 PMID: 9783337
  7. Factors predictive of a beneficial response to therapy of hepatitis C.
    Hepatology. 1997 Sep;26(3 Suppl 1):122S-127S PMID: 9305676
  8. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
    Hepatology. 1997 Dec;26(6):1640-5 PMID: 9398010
  9. Monitoring of serum levels of HCV RNA in early phase of IFN therapy; as a predictive marker of subsequent response.
    Hepatogastroenterology. 1998 Jan-Feb;45(19):133-6 PMID: 9496502
  10. Multicenter evaluation of the COBAS AMPLICOR HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory.
    J Clin Microbiol. 1998 Apr;36(4):862-5 PMID: 9542899
  11. Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C.
    J Gastroenterol Hepatol. 1997 Jun;12(6):468-72 PMID: 9195406
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
1999-05-00
Pages
1567-9
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC84830
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com